ArticleThrombosis journal2023

Comparison of the efficacy and safety of rivaroxaban and low-molecular-weight heparin in Chinese lung cancer patients with nonhigh-risk pulmonary embolism.

Yijun Song et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.